Immunonutrition: Biomedical Basis for Disease Management
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 6674
Special Issue Editor
Interests: immunonutrition; macrophages; trained immunity; gut-liver axis; microbiota
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Knowledge about the impact of immunonutritional agonists on citizens’ health can offer a way to reduce the risk of suffering chronic diseases and even offer a therapeutic potential on these. Innate and adaptive immune effectors operate sequentially and in distinct ways during normal development to prevent alterations in tissue metabolic homeostasis as well as to establish steady-state commensalism. Those are key to correct the distinctive stamp in alterations to the homeostasis of nutrients, leading to immunometabolic-based diseases with a strong impact on future morbidity rates and a reduction in the life expectancy of the population (i.e., non-alcoholic fatty liver disease, metabolic syndrome, cancer). There is evidence of the relevance of perinatal nutrition to developmental programming of innate immune effectors, worsening or improving their contribution to the risk of disease development. Viewed in the context of innate immune biology, immunonutrition as coadjutant strategy to pharmacological approaches can represent a path forward to help to selectively develop and maintain durable and long-lasting immune response(s). However, there remain key unanswered questions about immunonutritional factors that overall require a concerted effort to overcome the usually fragmented and compartmentalized approach to address their impact. Identification and development of immunonutritional agonists, as well as definition of their biomedical action based on life sciences, can greatly accelerate our progress toward precision medicine in health promotion.
Dr. Jose Laparra Llopis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nutrients
- innate and adaptive lymphocytes
- myeloid cells
- cancer
- lipid homeostasis
- microbiota
